• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDIVATORS DSD-201; AUTOMATED ENDOSCOPE REPROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDIVATORS DSD-201; AUTOMATED ENDOSCOPE REPROCESSOR Back to Search Results
Device Problems Use of Incorrect Control/Treatment Settings (1126); Off-Label Use (1494)
Patient Problems Chemical Exposure (2570); No Known Impact Or Consequence To Patient (2692)
Event Date 10/16/2018
Event Type  Injury  
Manufacturer Narrative
It was reported that a facility was reprocessing endoscopes in their dsd-201 automated endoscope reprocessor (aer) with the incorrect amount of rinses per the high-level disinfectant labeling and aer instructions-for-use.The facility was using metricide opa hld which requires 3 rinses but their aer was set up with 2 rinses.There is potential that endoscopes may have contained hld residual after reprocessing which could cause chemical colitis or adverse reactions to patients.While onsite to perform a preventative maintenance service, medivators field service engineer (fse) discovered that the facility originally had their aer set up for using rapicide opa/28 hld which requires 2 rinses.The facility switched to using metricide opa that morning but did not change the aer settings to add the third rinse per the hld labeling.Medivators fse informed the facility of the required 3 rinses for use with metricide opa and changed the aer settings to have the correct amount of rinses.It is estimated 20-30 endoscopes were reprocessed that day before medivators fse arrived onsite and updated the aer parameter settings.As stated in the dsd-201 user manual, operators are required to ensure the aer is set up with the correct parameter settings in accordance with the hld manufacturer's labeling and instructions.There were no reports of patient harm.This complaint will continue being monitored in medivators complaint handling system.
 
Event Description
It was reported that a facility was reprocessing endoscopes in their dsd-201 automated endoscope reprocessor (aer) with the incorrect amount of rinses per the high-level disinfectant labeling and aer instructions-for-use.The facility was using metricide opa hld which requires 3 rinses but their aer was set up with 2 rinses.There is potential that endoscopes may have contained hld residual after reprocessing which could cause chemical colitis or adverse reactions to patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DSD-201
Type of Device
AUTOMATED ENDOSCOPE REPROCESSOR
Manufacturer (Section D)
MEDIVATORS
14605 28th ave n
minneapolis MN 55447
Manufacturer (Section G)
MEDIVATORS
14605 28th ave n
minneapolis MN 55447
Manufacturer Contact
alex nelson
14605 28th ave n
minneapolis, MN 55447
7635094799
MDR Report Key8063992
MDR Text Key126924580
Report Number2150060-2018-00071
Device Sequence Number1
Product Code FEB
UDI-Device Identifier00677964033858
UDI-Public00677964033858
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K914145
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Non-Healthcare Professional
Remedial Action Modification/Adjustment
Type of Report Initial
Report Date 11/13/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? Yes
Date Manufacturer Received10/16/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/01/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-